WALL STREET ASSOCIATES - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 129 filers reported holding ARATANA THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
WALL STREET ASSOCIATES ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$1,007,000
-45.5%
140,300
-28.9%
0.67%
+5.7%
Q3 2016$1,848,000
+75.2%
197,400
+192.0%
0.63%
+592.3%
Q2 2014$1,055,000
-24.5%
67,597
-10.2%
0.09%
-20.2%
Q1 2014$1,398,00075,2970.11%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders